BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 30474366)

  • 21. Acid-Liable Cleavage of Doxorubicin@Plunoric-Carbon Dots in Multiplexed Bioimaging and Drug Delivery.
    Priyadarshini E; Rajamani P
    AAPS PharmSciTech; 2020 Nov; 21(8):322. PubMed ID: 33200276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbon nanoparticles suspension injection for the delivery of doxorubicin: Comparable efficacy and reduced toxicity.
    Huang Y; Xie P; Yang ST; Zhang X; Zeng G; Xin Q; Tang XH
    Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():416-423. PubMed ID: 30184767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PEG-Detachable Polymeric Micelles Self-Assembled from Amphiphilic Copolymers for Tumor-Acidity-Triggered Drug Delivery and Controlled Release.
    Xu M; Zhang CY; Wu J; Zhou H; Bai R; Shen Z; Deng F; Liu Y; Liu J
    ACS Appl Mater Interfaces; 2019 Feb; 11(6):5701-5713. PubMed ID: 30644711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. pH-responsive unimolecular micelle-gold nanoparticles-drug nanohybrid system for cancer theranostics.
    Lin W; Yao N; Qian L; Zhang X; Chen Q; Wang J; Zhang L
    Acta Biomater; 2017 Aug; 58():455-465. PubMed ID: 28583900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-Sensitive Biodegradable Nanoparticles of Molecularly Imprinted Polymer-Stabilized Fluorescent Zeolitic Imidazolate Framework-8 for Targeted Imaging and Drug Delivery.
    Qin YT; Feng YS; Ma YJ; He XW; Li WY; Zhang YK
    ACS Appl Mater Interfaces; 2020 Jun; 12(22):24585-24598. PubMed ID: 32390415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Well-Defined Poly(Ortho Ester Amides) for Potential Drug Carriers: Probing the Effect of Extra- and Intracellular Drug Release on Chemotherapeutic Efficacy.
    Yan G; Wang J; Qin J; Hu L; Zhang P; Wang X; Tang R
    Macromol Biosci; 2017 Jul; 17(7):. PubMed ID: 28371012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrin-targeted zwitterionic polymeric nanoparticles with acid-induced disassembly property for enhanced drug accumulation and release in tumor.
    Huang P; Song H; Wang W; Sun Y; Zhou J; Wang X; Liu J; Liu J; Kong D; Dong A
    Biomacromolecules; 2014 Aug; 15(8):3128-38. PubMed ID: 25054812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amphiphilic peptide dendritic copolymer-doxorubicin nanoscale conjugate self-assembled to enzyme-responsive anti-cancer agent.
    Li N; Li N; Yi Q; Luo K; Guo C; Pan D; Gu Z
    Biomaterials; 2014 Nov; 35(35):9529-45. PubMed ID: 25145854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoscaled poly(L-glutamic acid)/doxorubicin-amphiphile complex as pH-responsive drug delivery system for effective treatment of nonsmall cell lung cancer.
    Li M; Song W; Tang Z; Lv S; Lin L; Sun H; Li Q; Yang Y; Hong H; Chen X
    ACS Appl Mater Interfaces; 2013 Mar; 5(5):1781-92. PubMed ID: 23410916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Charge-Convertible Carbon Dots for Imaging-Guided Drug Delivery with Enhanced in Vivo Cancer Therapeutic Efficiency.
    Feng T; Ai X; An G; Yang P; Zhao Y
    ACS Nano; 2016 Apr; 10(4):4410-20. PubMed ID: 26997431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative-charge-functionalized mesoporous silica nanoparticles as drug vehicles targeting hepatocellular carcinoma.
    Xie M; Xu Y; Shen H; Shen S; Ge Y; Xie J
    Int J Pharm; 2014 Oct; 474(1-2):223-31. PubMed ID: 25149125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid fabrication of carbon quantum dots as multifunctional nanovehicles for dual-modal targeted imaging and chemotherapy.
    Chiu SH; Gedda G; Girma WM; Chen JK; Ling YC; Ghule AV; Ou KL; Chang JY
    Acta Biomater; 2016 Dec; 46():151-164. PubMed ID: 27662808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of zwitterionic polymer-based doxorubicin conjugates: tuning the surface charge to prolong the circulation and reduce toxicity.
    Wang Z; Ma G; Zhang J; Lin W; Ji F; Bernards MT; Chen S
    Langmuir; 2014 Apr; 30(13):3764-74. PubMed ID: 24617705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activity.
    Zhao S; Yu Q; Pan J; Zhou Y; Cao C; Ouyang JM; Liu J
    Acta Biomater; 2017 May; 54():294-306. PubMed ID: 28267598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrin-mediated active tumor targeting and tumor microenvironment response dendrimer-gelatin nanoparticles for drug delivery and tumor treatment.
    Hu G; Zhang H; Zhang L; Ruan S; He Q; Gao H
    Int J Pharm; 2015 Dec; 496(2):1057-68. PubMed ID: 26598487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.
    Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S
    Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zwitterionic nanoparticles constructed with well-defined reduction-responsive shell and pH-sensitive core for "spatiotemporally pinpointed" drug delivery.
    Huang P; Liu J; Wang W; Li C; Zhou J; Wang X; Deng L; Kong D; Liu J; Dong A
    ACS Appl Mater Interfaces; 2014 Aug; 6(16):14631-43. PubMed ID: 25100635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absolutely "off-on" fluorescent CD-based nanotheranostics for tumor intracellular real-time imaging and pH-triggered DOX delivery.
    Dong Y; Du P; Liu P
    J Mater Chem B; 2020 Sep; 8(35):8002-8009. PubMed ID: 32761044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A54 Peptide Modified and Redox-Responsive Glucolipid Conjugate Micelles for Intracellular Delivery of Doxorubicin in Hepatocarcinoma Therapy.
    Liu N; Tan Y; Hu Y; Meng T; Wen L; Liu J; Cheng B; Yuan H; Huang X; Hu F
    ACS Appl Mater Interfaces; 2016 Dec; 8(48):33148-33156. PubMed ID: 27934140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. pH-Sensitive nanoparticles as smart carriers for selective intracellular drug delivery to tumor.
    Li XX; Chen J; Shen JM; Zhuang R; Zhang SQ; Zhu ZY; Ma JB
    Int J Pharm; 2018 Jul; 545(1-2):274-285. PubMed ID: 29733971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.